# Goodbody Health to de-list from CSE to better align corporate structure

- Link: https://www.directorstalkinterviews.com/goodbody-health-to-de-list-from-cse-to-better-align-corporate-structure/4121068175
- Published: 2022-06-10T13:15:54+01:00
- Author: Amilia Stone

**Goodbody Health Inc.** ([AQSE:GDBY](https://www.directorstalkinterviews.com/company/goodbody-health/gdby.cn))
has announced its intention to de-list from the Canadian Securities Exchange and
to re-domicile the Company from the Province of British Columbia to Guernsey, subject
to shareholder approval. This re-domiciliation is intended to better align Goodbody’s
corporate structure with its current and future business activities.

Goodbody has a substantial business presence in the United Kingdom and the European
Union, including all of its operations, management and workforce. In addition, the
fastest-growing segments of Goodbody, are currently in the United Kingdom.

Goodbody does not anticipate any impact for employees, day-to-day operations, or
products and services as a result of the re-domiciliation, and Goodbody intends 
to retain its listing on the AQSE Growth Market in London and the OTCQB in North
America, which will ensure that trading in the Company’s shares remains possible
for both UK and North American investors.

Goodbody’s Board of Directors believes that the proposed plan to change its location
of incorporation from the Province of British Columbia to Guernsey will provide 
the Company with many benefits, including:

·    Positions the Company in proximity to a leading global financial centre and
Europe’s transaction hub (London), a location where it has substantial existing 
business activities and significant opportunities for continued growth;

·    Elevates the Company’s visibility among potential U.K. and other European institutional
investors;

·    Positions the Company to allow future earnings and cash flows to more efficiently
fund its ongoing U.K. and European expansion;

·    Reduces the costs and time spent procuring that the Company complies with the
requirements associated with two material listings that have entirely different 
regulatory regimes which will allow management to focus on commercial activities;
and

·    Reduces currency risk.

Shareholders will have the opportunity to vote on the proposed plan at the annual
general and special meeting expected to be held in August 2022. Subject to shareholder
approval, the Company anticipates that the change of the place of incorporation 
will become effective later in the third quarter of 2022.

Shareholders’ will continue to hold the exact number of shares, as they currently
hold in Goodbody Health common shares and their shareholdings will be unchanged 
following the re-domiciliation. As the Company will be subject to the laws of Guernsey
following the re-domiciliation, new articles of association of the Company will 
be adopted detailing the rights attaching to the Company’s shares. With effect from
the re-domiciliation, the Company’s common shares will be renamed as “ordinary shares”.
The Company also intends to have its common shares voluntarily de-listed from trading
on the CSE prior to or concurrently with the effective time of the re-domiciliation
and the Company also intends that its ordinary shares will continue to be admitted
to trading on the AQSE Growth Market in London.

The Company expects to publish a circular to propose the CSE de-listing of the Company
and re-domiciliation to Guernsey by no later than 19^(th) July 2022, being at least
21 days prior to the expected date of the Annual General Meeting.  The circular 
will include, amongst other things, particulars of the main differences between 
the Company’s current constitution and the new articles to be adopted pursuant to
the re-domiciliation.

**Change of Corporate Adviser**

Goodbody is pleased to announce that it has appointed Peterhouse Capital Limited
as the Company’s Corporate Adviser with immediate effect.

> **Geremy Thomas, Executive Chairman, said**: “With our clear strategic plan ahead
> of us we have to prioritise what is best for the shareholders. Following a lot
> of feedback, we have decided we need to simplify the business structure to enable
> us to focus our resources on growing what is becoming a very exciting business.”

You can find further information about the Company and its strategic direction in
the Financial Statements and Management Discussion and Analysis under the Company’s
profile on www.sedar.com.

Share on:
